Studies of oncogenes and tumor-suppressor genes in human thyroid carcinomas, and their clinical implications
✍ Scribed by P. E. Goretzki; Cornelia Dotzenrath; Dietmar Simon; Hans-Dietrich Röher
- Publisher
- Springer
- Year
- 1999
- Tongue
- English
- Weight
- 63 KB
- Volume
- 384
- Category
- Article
- ISSN
- 1435-2451
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The expression of nine oncogenes (c‐myc, N‐myc, N‐ras, H‐ras, k‐ras, abl, fos, src, and raf) and two tumor suppressor genes (p53 and RB) were studied by northern blot hybridization in six human hepatocellular carcinoma or hepatoblastoma cell lines (PLC/PRF/5, HepSB, Hep G2, 2.2.15, HLE,
## Abstract In multiple endocrine neoplasia syndrome Type 2 (MEN2), medullary thyroid carcinoma (MTC) and pheochromocytoma (PC) are associated with hereditary activating germ‐line mutations in the __RET__ proto‐oncogene. Also in a large percentage of sporadic MTCs and PCs, somatic __RET__ mutations
## Abstract ## BACKGROUND Recently, the __TSLC1__ (tumor suppressor in lung cancer 1) gene has been identified as a novel tumor suppressor in human nonsmall cell lung carcinoma. To the authors' knowledge, the clinical relevance of __TSLC1__ gene expression has not been studied using patient data a